Open AccessWarfarin treatment in stent thrombosis
Author(s) -
Abdulla Arslan,
Mehmet Eyüboğlu,
Erkan Alpaslan,
Asım Oktay Ergene
Publication year - 2016
Publication title -
international journal of the cardiovascular academy
Language(s) - English
Resource type - Journals
eISSN - 2618-6012
pISSN - 2405-8181
DOI - 10.1016/j.ijcac.2016.05.001
Subject(s) - medicine , clopidogrel , warfarin , conventional pci , percutaneous coronary intervention , thrombosis , stent , cardiology , asymptomatic , thrombus , complication , myocardial infarction , surgery , atrial fibrillation
A 62 year-old male patient was admitted to the hospital due to anterior ST segment elevated myocardial infarction. Thrombotic complication developed three times during the hospitalization after primary percutaneous coronary intervention (PCI). Instent thrombus was identified despite the optimal medical therapy, new antiplatelet agents and intravascular ultrasound guided PCI. Therefore, symptoms were controlled with warfarin + clopidogrel treatment. At the third month of warfarin + clopidogrel treatment, the patient was asymptomatic and no active electrocardiographic changes were observed. Stent thrombosis developing under new antiplatelet agents constitutes a great problem and there are no clear data for the solution. We described an interesting case in which we achieved symptomatic control by warfarin + clopidogrel in the stent thrombosis developing during the treatment with dual antiplatelet therapy